AstraZeneca awards $1.6 million for programs to improve access to healthcare for patients across the US
US ACT on Health Equity contributions support AstraZeneca’s long-term ambition in health equity and total more than $20 million to date
BioHealth Capital Region
Maryland, D.C., and Virginia — one of the largest life science corridors in the U.S.
Explore →
Greater Philadelphia
Philadelphia, South Jersey, and Delaware — a powerhouse of pharma and biotech innovation.
Explore →
Research Triangle Park
North Carolina's Research Triangle — a growing hub for biotech and life sciences.
Explore →Featured News
North Carolina
Career & Professional Development
North Carolina Life Sciences News: Fortrea’s $45 Million Acquisition, United Therapeutics FDA Approval & More
North Carolina – Regional Life Sciences Roundup -October 23th, 2026 Each week, our Regional Roundup delivers the most important and timely life sciences news from around the region. From groundbreaking research to fundraising, new development projects, and who’s hiring — we bring you the top stories that matter most. Stay informed with a curated selection […]
Read More →Our Partners
Latest News
I270 Tech Labs: Built for What Comes Next
For a small biotech or technology company, getting started can mean more than having a good idea. There is the lab space, the equipment, the infrastructure, and the cost of putting it all together. Doug Bane has spent years working around those challenges. Now, through I270 Tech Labs, he is building a space designed to […]
Omniose Announces Its Acquisition by AstraZeneca
The acquisition brings differentiated bioconjugation technology and expertise to complement AstraZeneca’s capabilities in bacterial vaccines and beyond
Luminoah Raises $25 Million Series B to Expand Access to Its FDA-Cleared Enteral Feeding System
Luminoah, a medical technology company modernizing enteral nutrition, today announced a $25 million Series B financing led by Sandbox Clinical Ventures, with participation from the Blue Venture Fund, GV (Google…
Annovis Announces Pricing of $21.0 Million Public Offering
MALVERN, Pa., Nov. 05, 2026 (GLOBE NEWSWIRE) — Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for…
Neuronetics Announces Pricing of $30 Million Underwritten Public Offering of Common Stock
MALVERN, Pa., Nov. 10, 2026 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM) (the “Company”) today announced the pricing of its previously announced underwritten public offering of its common stock, comprised of…
Buzzin’ Brood Student Spotlight: Gabriel Galeotos, George Washington University
BioBuzz’s Buzzin’ Brood Student Spotlight series celebrates the future of life sciences talent — and the programs, institutions, and organizations investing in them. Name: Gabriel Galeotos Hometown: Canton, Massachusetts Institution: George Washington University (Washington, DC) Role: PhD Candidate, Rebecca Lynch Lab, George Washington University For Gabriel Galeotos, a career in medical research was inspired by […]
Theradaptive Brings Commercial Manufacturing Home with $15M Frederick Expansion
FREDERICK, Md. — Regenerative medicine company Theradaptive celebrated the opening of its $15 million manufacturing expansion with a ribbon-cutting ceremony on Oct. 29, 2026, at its Frederick County headquarters, joined by elected officials and representatives from federal, state, county and city government. The 23,000-square-foot facility brings commercial-scale GMP manufacturing in-house, placing the company’s research, development […]
More Than a Lab Coat: Industry Leaders Redraw the Map of Bio-Health Careers at Loyola
Ask most college students what a career in life sciences looks like, and they’ll picture a lab coat, a microscope and a bench full of samples. On Oct. 22, six industry professionals spent an evening at Loyola University Maryland taking that picture apart. Hosted by Loyola’s Rizzo Career Center, the panel brought together six leaders […]